Genetic immunization against neu/erbB2 transgenic breast cancer

Cancer Immunology Immunotherapy

Volumn 47, Issue 4, 1998, Pages 183-190

  Amici, Augusto ^a   Venanzi, Franco Maria ^a   Concetti, Antonio ^a  

^a Department of Biology MCA   (Italy)

Author keywords

Breast cancer; DNA immunization; Neu erbB2 oncogene; Thl autoimmunity; Transgenic mice

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BREAST CANCER; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; FEMALE; HELPER CELL; INTRAMUSCULAR DRUG ADMINISTRATION; METASTASIS; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR NECROSIS;

ADENOCARCINOMA; ANIMALS; AUTOIMMUNITY; BREAST NEOPLASMS; CANCER VACCINES; DISEASE MODELS, ANIMAL; DNA, NEOPLASM; FEMALE; GENES, ERBB-2; HUMANS; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; MUTATION; NEOPLASM TRANSPLANTATION; RATS; RECEPTOR, ERBB-2;

EID: 0032446987     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050519     Document Type: Article

References (33)

1. Attanasio R, Pheler K, Scinicariello F (1997) DNA-based immunization induces anti-CD4 antibodies directed primarly to native epitopes. FEMS Immun Med Microbiol 17:207
2. Bargmann CI, Hung UC, Weinberg RA (1986) Multiple independent activation of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649
3. Bernards R, Destree A, Mc Kenzie S, Gordon E, Weinberg RA, Panicali D (1987) Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector. Proc Natl Acad Sci USA 84:6854
4. Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Quin HL, Takahashi M, Chen W (1995) Immunity to oncogenic proteins. Immunol Rev 145:33
5. Concetti A, Amici A, Petrelli C, Tibaldi A, Provinciali M, Venanzi FM (1996) Autoantibody to p185erbB2/neu onco-protein by vaccination with xenogenic DNA. Cancer Immunol Immunother 43:307
6. Conry RM, Lo Buglio AF, Kantor J, Shlom J, Loediel F, Moore SE, Samerel LA, Barlow DL, Abrams S, Curiel DT (1994) Immune response to carcinoembryonic antigen polynucleotide vaccine. Cancer Res 54:1164
7. Disis M, Smith JW, Murphy AE, Chen W, Cheever MA (1994) In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein. Cancer Res 54:1071
8. Disis ML, Calenoff E, Mc Laughlin G, Murphy AE, Chen W, Groner Jeschke M, Lydon N, Mc Glynn E, Livingston RB (1994) Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res 54:16
9. Fisk B, Blevins TL, Wharton JT, Ioannides CG (1995) Identification of an immunodominant peptide to HER-2/neu protooncogene recognized by ovarian tumor specific cytotoxic T lymphocytes lines. J Exp Med 181:2109
10. Guy CT, Webster MA, Shaller M, Parson TJ, Cardiff RD, Muller WJ (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89:10578
11. Halpern MD, Kurlander RJ, Pisetsky DS (1996) Bacterial DNA induces murine interferon-gamma production by stimulation of interleukine-12 and tumor necrosis factor-alpha. Cell Immunol 167:72
12. Havell EA, Fiers W, North RJ (1988) The antitumor function of tumor necrosis factor (TNF) (I). J Exp Med 167:1076
13. Houghton AN (1994) Cancer antigens immune recognition of self and altered self. J Exp Med 18:1-4; Nat Med 1:644-648
14. Houghton AN (1994) Cancer antigens immune recognition of self and altered self. J Exp Med 18:1-4; Nat Med 1:644-648
15. Hynes NE, Stern DF (1994) The biology erbB2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198:165
16. Katsumata M, Okudaira T, Samata A, Clark DP, Debrin JA, Jolicoeur P, Greene MI (1995) Prevention of breast tumor development in vivo by downregulation of the p185neu receptor. Nat Med 1:644
17. Leclere C, Deriaud E, Rojas M, Whalen RG (1997) The preferential induction of a Th1 immunoresponse by DNA-based immunization is mediated by the immunomodulatory effect of plasmid DNA. Cell Immunol 179:97
18. Luster A, Unkeless J, Ravetch J (1985) Gamma-interferon transcriptionally regulates an early response gene containing homology to platelet proteins. Nature 315:672
19. Martinez X, Brandt C, Saddallah F, Tougne C, Barrios C, Wild F, Dougan G, Lambert PH, Siegrist CA (1997) DNA immunization circumvents deficent induction of T helper type 1 and cytotoxic T lymphocytes response in neonates and during early life. Proc Natl Acad Sci USA 94 :8726
20. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 64:105
21. Musiani P, Modesti A. Giovarelli M, Cavallo F, Colombo MP, Lollini PL, Forni G (1997) Cytokine, tumor-cell death and immunogenicity: a question of choice. Immunol Today 18:32
22. Nada NK, Sercaz EE (1995) Induction of anti-self immunity to cure cancer. Cell 82:13
23. Nagata Y, Furugen R, Hiasa A, Ikeda H, Ohta N, Furukawa K, Nakamura H, Furukavva K, Kanematsu T, Shiku H (1997) Peptides derived from a wild type murine proto-oncogene-erbB2/Her2/ neu can induce CTL and tumor suppression in syngenic hosts. J Immunol 159:1336
24. Nawroth P, Bank I, Handley D, Cassimeris J, Chess L, Stern D (1986) Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukine-1. J Exp Med 163:1363
25. Nisticò P, Mattolese M, Mammi C, Benevolo M, Del Bello D, Rubio O, Gentile FP, Botti C, Venturo I, Natali PG (1997) Low frequency of erbB2 protooncogene overexpression in human leukocyte antigen-A2-positive breast cancer patients. J Natl Cancer Inst 89:319
26. Pan ZK, Ikonomidis G, Lazenby A, Pardoll D, Palerson Y (1995) A recombinant Listeria monocytogenes vaccine expressing a model tumor antigen protects mice against lethal tumor cell challenge and causes regression of established tumors. Nat Med 1:471
27. Park JW, Stags R, Lewis GD, Carter P, Maneval D, Slamon DJ, Jaffe H, Shepard HM (1992) In: Dickson RB, Lipmmann ME (eds) Genes, oncogenes and hormones: advances in cellular and molecular biology of breast cancer. Kluver, Boston, p 193
28. Sgadari C, Angiolillo AN, Cherney BW, Pike SE, Farber JM, Koniaris LG, Vanguri P, Burd PR, Sheikh N, Gupta G, Teruja-Feldestein J, Tosato G (1996) Interferon-inducible protein-10 identified as a mediator of tumor necrosis factor in vivo. Proc Natl Acad Sci USA 93:13791
29. Slamon DJ, Godolphin W, Jones L, Holt J, Wang S, Keith D, Levin W, Struart S, Ullrich A, Press M (1989) Studies of the HER-2/neu protooncogene in human breast and ovary cancer. Science 244:707
30. Staus HJ, Dha LM (1996) In: Dalglish AG, Browning M (eds) Tumor immunology. Cambridge University Press, Cambridge p 153
31. Stancovski I, Hurwitz E, Leitner O, Ullrich A, Yarden Y, Sela M (1991) Mechanistic aspects of the opposing effect of monoclonal antibodies to the erbB2 receptor on tumor growth. Proc Natl Acad Sci USA 88:8691
32. Van Dyke MW, Sirito M, Sawadogo M (1992) Single-step purification of bacterially expressed polypeptides containing an oligo-histidine domain. Gene 111:99
33. Venanzi FM, Petrelli C, Concetti A, Amid A (1995) neu/HER-2 c-DNA vaccination and pregnancy loss. Ann NY Acad Sci 772:274